BridgeBio Pharma LLC Signs Joint Collaboration Agreement With Cincinnati Children's To Accelerate Development Of Genetic Disease Therapeutics
Monday, November 12, 2018 1 min read
Key Takeaway: BridgeBio Pharma LLC Signs Joint Collaboration Agreement With Cincinnati Children's To Accelerate Development Of Genetic Disease Therapeutics
Full Press Release Details
BridgeBio Pharma LLC Signs Joint Collaboration Agreement With Cincinnati Children's To Accelerate Development Of Genetic Disease Therapeutics.